Clinical Trials Directory

Trials / Unknown

UnknownNCT05518240

Comparison of Solitaire to Embotrap to Treat Large Vessel Occlusion in Acute Ischemic Stroke (SOLTRAP Study)

Status
Unknown
Phase
Study type
Observational
Enrollment
418 (estimated)
Sponsor
WellStar Health System · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The primary aim of this study is to assess if there is a difference in first pass reperfusion between the two devices. This is a randomized prospective study to assess if there is a difference in first pass reperfusion at two centers with large mechanical thrombectomy volumes. Data will also be collected on time-to treatment, outcomes and hemorrhagic complications.

Detailed description

The SOLTRAP Study is an investigator initiated two hospital study designed to assess the procedural success and clinical outcomes associated with mechanical thrombectomy using the Medtronic Solitaire Device and the Cerenovous Embotrap device. Both devices are FDA approved for this indication of removal of a thrombus for patients suffering from stroke secondary to a large vessel occlusion. Data collected will include device used during the procedure, mechanical thrombectomy techniques, time from onset to imaging, imaging to puncture, and overall time from onset to reperfusion as well as quality of life at 90 days post stroke. The study will enroll up to 418 subjects and will be conducted at Wellstar North Fulton Hospital and Wellstar Kennestone Hospital. The devices will have regulatory authorization to be on the market in the geographic location of both sites. The duration of the Registry protocol is approximately 24 months

Conditions

Interventions

TypeNameDescription
DEVICEStent RetrieversProcedure: Embotrap device
DEVICEStent RetrieverProcedure: Solitaire device

Timeline

Start date
2022-08-24
Primary completion
2024-08-07
Completion
2025-01-01
First posted
2022-08-26
Last updated
2022-08-26

Locations

2 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05518240. Inclusion in this directory is not an endorsement.